P2D Bioscience Announces Enhanced Patent Position for Lead ADHD Drug

 | Quelle: P2D Bioscience P2D Bioscience

CINCINNATI, OH and MUMBAI, INDIA--(Marketwire - Apr 26, 2011) -
www.p2dinc.com

Tags

patent protection ADHD drugs ADHD treatments ADHD drug side effects U.S. patent Canadian patent

Weiterführende Links

FirmenprofilP2D Bioscience
Aktionen für die Pressemitteilung